-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/Lion-Mangione-Britto.pdf
October 01, 2011 - Altman, 2009, PLoS Medicine, 6(6), e100097. http://dx.doi
.org/10.1371/journal.pmed1000097. … The two cohort studies among adults also achieved positive
outcomes in some domains. … Following crossover to intervention, parents
reported improvements in satisfaction in multiple domains … Function: Family functioning improved across multiple domains (p , .05). … Function: Intervention patients had improved asthma-specific functional status
in 2 out of 5 domains
-
www.innovations.ahrq.gov/pqmp/measures/afebrile-atraumatic-seizure.html
August 01, 2021 - Technical Specifications (PDF, 227.25 KB) Section 5, Table 10; Figures 1 & 2 (PDF, 290.7 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/communication-weight-classification.html
August 01, 2021 - 80 KB) Section 2, Technical Specifications (PDF, 94 KB) Section 5, Table 2 (PDF, 136 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/discussion-weight-concerns.html
August 01, 2021 - 80 KB) Section 2, Technical Specifications (PDF, 82 KB) Section 5, Table 2 (PDF, 131 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/post-traumatic-headache.html
August 01, 2021 - Section 2, Detailed Measure Specifications (PDF, 281 KB) Section 5, Figures 1-3 (PDF, 216 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/monitor-depression-symptoms.html
August 01, 2021 - Specifications and Other Supporting Documents: Section 2, Technical Specifications (PDF, 1.1 MB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/timely-temperatures-upon-arrival.html
August 01, 2021 - PDF, 65 KB) Section 3.A, Figures 1 and 2 (PDF, 115 KB) Section 3.B, Figure A (PDF, 133 KB) Section 6.
-
www.innovations.ahrq.gov/pqmp/measures/depression-screening.html
August 01, 2021 - Specifications and Other Supporting Documents: Section 2, Technical Specifications (PDF, 1.3 MB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/overuse-tomography-atraumatic-headache.html
August 01, 2021 - –7 (PDF, 440 KB) Section 5, Figures 1 & 2 (PDF, 133 KB) Section 5, Table 8 (PDF, 138 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/pediatric-respiratory-infection-readmissions.html
August 01, 2021 - Documents: Section 2, Detailed Measure Specifications (15 MB) Section 5, Tables 8 and 9 (195 KB) Section 6-
-
www.innovations.ahrq.gov/pqmp/measures/higher-than-recommended-doses-antipsychotics.html
August 01, 2021 - Specifications and Other Supporting Documents: Section 2, Technical Specifications (PDF, 574 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/multiple-concurrent-antipsychotics.html
August 01, 2021 - Technical Specifications (PDF, 102 KB) Section 5.A, Research Evidence Table (PDF, 150 KB) Section 6.
-
www.innovations.ahrq.gov/pqmp/measures/pediatric-medical-complexity-algorithm.html
August 01, 2021 - Levels of Medical Complexity (PDF, 125 KB) Section 2, Technical Specifications (PDF, 38 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/metabolic-monitoring-antipsychotics.html
August 01, 2021 - Technical Specifications (PDF, 333 KB) Section 5, Appendix 1, Tables 1 to 5 (PDF, 238 KB) Section 6,
-
www.innovations.ahrq.gov/pqmp/measures/asthma-rate-ed-visit.html
August 01, 2021 - KB) Section 2, Technical Specifications (PDF, 46,5 KB) Section 3, Figure 2 (PDF, 90.7 KB) Section 6.
-
www.innovations.ahrq.gov/pqmp/measures/scd-confirmatory-testing.html
August 01, 2021 - Table 6 (PDF, 41 KB) Section 8.
-
www.innovations.ahrq.gov/pqmp/measures/timely-antibiotics.html
August 01, 2021 - 163 KB) Section 2, Technical Specifications (PDF, 165 KB) Section 5, Table 4 (PDF, 175 KB) Section 6,
-
www.innovations.ahrq.gov/policymakers/chipra/pubs/background-2012/index.html
December 01, 2012 - Responsive to the child health needs, services, and domains of health care quality described in clauses … (i), (ii), and (iii) of subsection (a)(6)(A). … The desirable measure attributes included specific domains identified in the CHIPRA legislation (e.g. … "Medium" (scores 4–6).
"High" (scores 7–9). … set of quality measures should evolve over time, in the context of the comprehensive set of CHIPRA domains
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - the clinician should screen for
ADHD by specifically asking questions regarding the major symptom
domains … classification/rating scheme described at end of this document
Page 1 of 6 … For elementary school-age children (6 through 11 years of age),
the primary care clinician should prescribe … Evidence Ranking/Rating*
Treatment American
Academy of Child
Adolescent
Psychiatry
Recommendation 6. … Evidence classification/rating scheme described at end of this document Page 6
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/LomotanDougherty2013.pdf
April 01, 2013 - In addition,
CHIPRA called for quality measures in the quality domains
of access (e.g., availability … (PQMP) to fill gaps left by the
initial core set and to develop quality measures under all of
the domains … PQMP Overuse and misuse – antipsychotic medications [29]
assignment
Crosses multiple conditions or domains … Pediatrics. 2011;128(6):e1459–e66.
29. Seida JC, Schouten JR, Boylan K, et al. … Health Aff. 2005;24(5):1364–6.
40. Anderson KM, Marsh CA, Flemming AC, et al.